Filing Details
- Accession Number:
- 0000920465-18-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-03 21:55:43
- Reporting Period:
- 2017-12-29
- Accepted Time:
- 2018-01-03 21:55:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920465 | La Jolla Pharmaceutical Co | LJPC | Biological Products, (No Disgnostic Substances) (2836) | 330361285 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1589362 | L. Laura Douglass | C/O La Jolla Pharmaceutical Company, 4550 Towne Centre Court San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-29 | 6,000 | $10.84 | 6,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-12-29 | 4,000 | $6.00 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-29 | 10,000 | $32.32 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-29 | 6,000 | $0.00 | 6,000 | $10.84 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-29 | 4,000 | $0.00 | 4,000 | $6.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-04-03 | No | 4 | M | Direct | |
| 14,000 | 2023-11-21 | No | 4 | M | Direct |
Footnotes
- Represents the average sale price, with individual sale prices ranging from $32.29 to $32.49 per share. The reporting person will provide the Staff of the Securities and Exchange Commission or a shareholder with individual sales price information, if requested.
- This option represents a right to purchase a total of 6,000 shares of the Issuer's Common Stock, one third of which shall be fully vested and exercisable on April 3, 2015, with the remaining 4,000 shares vesting quarterly thereafter over the next two years.
- These options represent a right to purchase a total of 18,000 shares of the Issuer's Common Stock, one quarter of which shall be fully vested and exercisable on October 14, 2014, with the remaining 13,500 shares vesting monthly thereafter over the next three years in 36 equal increments of 375 shares.
Billionaire Hedge Funds
